5-52800570-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015946.5(PELO):āc.176A>Gā(p.Asn59Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015946.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PELO | NM_015946.5 | c.176A>G | p.Asn59Ser | missense_variant | 2/3 | ENST00000274311.3 | |
ITGA1 | NM_181501.2 | c.61+12156A>G | intron_variant | ENST00000282588.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PELO | ENST00000274311.3 | c.176A>G | p.Asn59Ser | missense_variant | 2/3 | 1 | NM_015946.5 | P1 | |
ITGA1 | ENST00000282588.7 | c.61+12156A>G | intron_variant | 1 | NM_181501.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000999 AC: 25AN: 250316Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135280
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461384Hom.: 0 Cov.: 32 AF XY: 0.0000536 AC XY: 39AN XY: 726954
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.176A>G (p.N59S) alteration is located in exon 2 (coding exon 1) of the PELO gene. This alteration results from a A to G substitution at nucleotide position 176, causing the asparagine (N) at amino acid position 59 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at